PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
University of Pennsylvania · Parker Institute for Cancer Immunotherapy · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
493
total citations
- FWCI
- 44.41
- Percentile
- 100%
- References
- 85
Citations per year
Authors
69Topics & keywords
Topics
Keywords
- Prostate cancer
- Chimeric antigen receptor
- Medicine
- Tumor microenvironment
- Antigen
- Cytokine
- Cancer
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.